The EU AI Act, Explained: What U.S. Companies Need to Understand
Risk tiers, prohibited practices, high-risk systems, when U.S. companies fall under it, and timelines for enforcement.
\n\n
Articles, guides, and perspectives on HIPAA, CMMC, ITAR, AI governance, cybersecurity, and privacy — written for leaders navigating modern compliance.
Risk tiers, prohibited practices, high-risk systems, when U.S. companies fall under it, and timelines for enforcement.
Foundational explainer of ITAR, USML, what triggers ITAR jurisdiction, and the consequences of getting it wrong.
Survey of every state with comprehensive privacy law, common patterns, key differences, and how to build a compliance program that handles them all.
Structure and required sections, real examples of policy clauses, how to handle approved vs prohibited use, and how to enforce a policy.
StateRAMP, TX-RAMP, common state procurement security requirements, and how to position to sell to state and local government buyers.
How regulators are treating AI bias under existing laws (employment, lending, housing), and what compliance teams should be doing about it now.
How to quantify compliance benefits beyond avoiding fines: contract wins, insurance reductions, customer trust, M&A premium. Building a CFO-ready case.
Questions to ask AI vendors, contract terms that matter for AI specifically, how AI complicates traditional vendor risk programs.
What board reports should contain, common mistakes (too technical, too long, no business framing), and the metrics directors care about.
The four functions (Govern, Map, Measure, Manage), how to apply the framework to a real organization, and why it's becoming the de facto AI governance…
The risks executives don't see when deploying AI in healthcare. ChatGPT in clinical settings, AI scribes, ambient listening, and BAA gaps.
FedRAMP impact levels, the authorization process, the cost and timeline, and the relationship to other federal frameworks.